Regulations for the Patent Linkage of Drugs Article 3
The invention scope of the drug patent set forth in Paragraph 2 of Article 48-3 of the Act shall include the following items:1. Substance: this refers to the active ingredients of drug preparations, including the inventions of polymorphic compounds.2. Composition or Formulation: this refers to the composition or formulation of the active ingredients of drug preparations.3. Medical use: this shall be in accordance with all or part of the indications recorded in the drug permit license.If the invention substance is a different polymorph of the active ingredient of drug preparations as stated in Item 1 of the preceding Paragraph, the test data demonstrated that a drug preparation containing the polymorph perform the equal effectiveness shall be provided when registration.The manufacturing process, intermediates, metabolites or packages of medicaments are exclusive of the inventions involved in the drug patent of Paragraph 1.
中文原文 西藥專利連結施行辦法第3條
本法第四十八條之三第二項所定藥品專利權之發明範圍,其內容如下:
一、物質:藥品製劑之有效成分,包括多形體不同化合形態之發明。
二、組合物或配方:藥品製劑有效成分之組合或配方。
三、醫藥用途:對應藥品許可證所記載適應症之全部或一部。
前項第一款物質發明為藥品製劑有效成分之不同多形體者,應於查驗登記有試驗資料證明,以該多形體物質作為有效成分之藥品製劑,有相同療效。
藥品之製程、中間體、代謝物或包裝者,非第一項藥品專利權之發明。
一、物質:藥品製劑之有效成分,包括多形體不同化合形態之發明。
二、組合物或配方:藥品製劑有效成分之組合或配方。
三、醫藥用途:對應藥品許可證所記載適應症之全部或一部。
前項第一款物質發明為藥品製劑有效成分之不同多形體者,應於查驗登記有試驗資料證明,以該多形體物質作為有效成分之藥品製劑,有相同療效。
藥品之製程、中間體、代謝物或包裝者,非第一項藥品專利權之發明。